Navigation Links
Singapore is First in Asia to Use Limb-lengthening Technology for Those Wanting to be Taller
Date:12/29/2008

Singapore was the first in Asia to carry out the high-tech cosmetic leg lengthening procedure in 2001. Fitbone surgery is presently available in only selected medical centers in Europe and Asia and costs around US $42,000 per telescope nail in Singapore.

Singapore (PRWEB) December 29, 2008 -- It was initially devised as a method of leg lengthening for those with congenital growth abnormalities or trauma to the lower limbs. However, since it was introduced in 2001, Fitbone surgery has without much fanfare, slipped into the realm of cosmetics.

Professor Sarbjit Singh, a Senior Consultant Orthopedic Surgeon at Singapore's renowned Mount Elizabeth Hospital, part of ParkwayHealth, was the first surgeon in Asia to carry out the high-tech procedure in 2001.

He maintains, "This procedure was meant to be an improvement over the older method of treating the limbs of polio or accident patients. However, seeing that it is much safer and more efficient, with less down-time and low risk of infection, it was inevitable that the good results would attract other uses."

The older Ilizarov method involves fitting the patient's leg within a circular frame using pins and wires pierced into the skin, muscles and bone. Screws attached to the bone are turned 1mm daily. After the growth gap is closed, patients then have to wear the frame until the new bone solidifies. However, since this involves placement of an external device into the skin, there is a high risk of infection at the point of entry.

Fitbone is essentially an advancement over this. De
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. A*STARs Singapore Immunology Network Is the First GeneGo Center of Excellence in Asia
2. Healthy Travel Media Launches Second Edition of Patients Beyond Borders Singapore Edition
3. Singapore Caters to Middle East Medical Travelers with Arabic Version of Patients Beyond Borders-Singapore Edition
4. Singapore Medicine - First in South East Asia to Offer Robotic Surgery for Gynaecologic Cancers
5. Abaxis, Inc. CEO to Present at the Eighth Annual Forbes Global CEO Conference in Singapore
6. Singapore Reinforces Position as a Global Site for Pharma & Biotech; Biomedical Manufacturing Output Quadruples to Reach US$17 Billion
7. Singapore Is One of the Fastest Growing Bioclusters in Asia; Wave of Investments in Drug Discovery and Translational Research
8. Jeffrey S. Williams Rejoins Alexza Pharmaceuticals as President, Alexza Singapore Pte. Ltd.
9. Marian Koshland Science Museum forms partnership with Science Center Singapore
10. Hospital Care in Singapore Now Available to American Patients at Pre-Negotiated, In-Network Rates Far Lower than Comparable Services in the U.S.
11. Wyeth to Expand State-of-the-Art Nutritional Manufacturing Facility in Singapore

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Singapore is First in Asia to Use Limb-lengthening Technology for Those Wanting to be Taller
Singapore is First in Asia to Use Limb-lengthening Technology for Those Wanting to be Taller
(Date:11/26/2009)... Ennis & Ennis, P.A. is offering free nationwi... Yasmin birth control pills who have suffered a De...ke, Heart Attack or other related cardiac issues o...ll free at 1-800-856-6405 or go to the firm’...t an online case evaluation form. , ...
(Date:11/25/2009)...,Nov.25/PRNewswire/-SentinelleMedicalInc.,aleading...dsoftwareandCalgaryScientificInc.,aleadingprovider...ersionofAegis(TM)Breast4DAdvancedVisualizationsoft...zero-footprintWebclientbasedmedicalimagingoffering...allowsforzero-footprintaccess-requiringnosoftwared...
(Date:11/25/2009).../PRNewswire-USNewswire/--TheBlackAIDSInstituterece...veleadershipfor2010. ,, ThenewBoardMembersareah...olicy,law,finance,governmenthealthprograms,editori...omawiderangeofpersonalbackgroundsincludingbothhete...emselves,andrepresentingmultipleagegroups. ,, (...
(Date:11/25/2009)...evidence of a statistically significant survival b...e estrogen receptor (ER)-positive tumors had high ...18 (ER-alpha S118-P), according to a brief communi...l of the National Cancer Institute . , Approxima...oxifen. Preclinical studies have shown that ER-alp...
(Date:11/25/2009)...o fight rheumatoid arthritis, could help newly dia...DAY, Nov. 25 (HealthDay News) -- A drug commonly u... arthritis now also shows some promise in helping ..., The drug, rituximab (Rituxan), helped patients k...gh the disease had destroyed some of their pancrea...
Breaking Medicine News(10 mins):Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3
... studies on subject, researchers note , , ...been enough studies to tell whether aspirin reduce...th the blocked leg blood vessel condition called p...studies of aspirin use with peripheral arterial di...
...ear-old Alexander, it,s meant orthotics and physic... For 7-year-old Rebecca, it,s an insulin pump for ...o has cerebral palsy, it,s a wheelchair. , , All ... help pay for desperately needed medical care or e...
...e More Informed Decisions When Choosing Nutritiona...ews stories on steroid use in sports continue to e...ements and sports nutrition products for banned su...o protecting and improving public health, has laun...
...s and experts will gather in New Orleans on June 1...ealth and property damage controversy involving bu...hey also are gathering for two teleconferences dea...least 13 states and the District of Columbia have ...
... posed by other strains of influenza, CDC says , ...health officials said Tuesday that they,re seeing ...ne flu continues to spread across the country. , "... severe complications in women with this year,s no...
...sTek, the leader in innovative electronic patient ...tion for clinical trials has continued its investm...ssisTek,s ongoing development of Smart Phone and e...9 -- assisTek, the leader in innovative electroni...
Other Medicine News:Health News:Aspirin Lowers Stroke Risk in Peripheral Artery Disease 2Health News:Aspirin Lowers Stroke Risk in Peripheral Artery Disease 3Health News:UnitedHealthcare Children's Foundation To Award More Medical Grants for Child Health Care Needs in New Jersey 2Health News:New Online Resource for Consumers, Athletes and Coaches Concerned About Athletic Banned Substances 2Health News:Chinese Drywall Litigation Subject of Conference and Two Teleconferences 2Health News:Swine Flu May Pose Problems for Pregnant Women 2Health News:Swine Flu May Pose Problems for Pregnant Women 3Health News:Swine Flu May Pose Problems for Pregnant Women 4Health News:Swine Flu May Pose Problems for Pregnant Women 5Health News:Swine Flu May Pose Problems for Pregnant Women 6Health News:Swine Flu May Pose Problems for Pregnant Women 7Health News:Swine Flu May Pose Problems for Pregnant Women 8Health News:Swine Flu May Pose Problems for Pregnant Women 9Health News:Smart Phone, ePRO, and eDiary Technology Advances for Clinical Trials, Market Research, and Registries Reported by assisTek 2Health News:Smart Phone, ePRO, and eDiary Technology Advances for Clinical Trials, Market Research, and Registries Reported by assisTek 3
(Date:11/24/2009)...REMONT,Calif.,Nov.24/PRNewswire-FirstCall/--Vermil...nyfileditsPlanofReorganizationandDisclosureStateme...tcyCourtfortheDistrictofDelaware.Ahearingtoconside...ledforDecember8,2009,withthehearingontheconfirmati...ncallsfortheCompanytopayallclaimsinfull.ThePlanise...
(Date:11/24/2009)...OODCLIFFLAKE,N.J.andNEWYORK,Nov.24/PRNewswire/-- ...andDrugAdministration(FDA)hasacceptedforreviewEisa...#174;(donepezilHClextendedrelease)tabletsforthetre...snewhigherdoseformulationcontains23mgofdonepezilHC...ysystemthatallowsforgradualreleaseofthedrug.TheNDA...
(Date:11/24/2009)...LEASANTON,Calif.,Nov.24/PRNewswire-FirstCall/--Tho...ce-basedmechanicalcirculatorysupporttherapiestosav...llbeparticipatinginthe21stAnnualPiperJaffrayHealth...ith,executivevicepresidentandchieffinancialofficer...m.,EasternStandardTime(5:30a.m.,PacificStandardTim...
Breaking Medicine Technology:Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 3Curemark Announces Senior Executive Promotions 5301 1Curemark Announces Senior Executive Promotions 5301 2Curemark Announces Senior Executive Promotions 5301 3Lab on a Chip Might Speed Breast Cancer Monitoring 59092 1Lab on a Chip Might Speed Breast Cancer Monitoring 59092 2Lab on a Chip Might Speed Breast Cancer Monitoring 59092 3Potential Pieces of Autism Puzzle Revealed 59089 1Potential Pieces of Autism Puzzle Revealed 59089 2
...EY HEIGHTS, NJ – June 4, 2007 – Genta,...tion of results,from a Phase 2 clinical trial of i...injection), plus rituximab (Rituxan®;,Genentec...d or,refractory non-Hodgkin’s lymphoma (NHL)... the American Society of Clinical,Oncology (ASCO) ...
...O--(BUSINESS WIRE)--Jun 4, 2007 - Introgen Therape...cal collaborators today,reported updated Phase 2 d...n abnormal p53, tumor responses and increased,surv... recurrent,squamous cell carcinoma of the head and...day at the annual meeting of the American,Society ...
Other Medicine Technology:Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 2Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 3Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 4Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 5Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker 2Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker 3Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker 4
LabDAQ3 Laboratory Information System
...ies to work more efficiently has never been higher...th the COBAS INTEGRA® 400 plus, innovation mea...ndling of reaction cuvettes and improved operator ...ease-of-use required for true workload consolidati...
...ng a non-contact diagnostic lens, doctors have to ...gh magnification. Now, with the Digital Wide Fiel...n have both in one lens. This lens provides the w...s paired with the higher magnification required fo...
...Anchor is a unique double loaded anchor perfect fo...y-L Lactic Acid (PLLA) and comes in two sizes: 5.0...nds for open repairs, and can easily be cut-off fo...lows insertion with minimal procedural steps and t...
Medicine Products: